InterCure Income Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	243.12	238.85	355.55	388.68	219.68	65.04
Revenue Growth (YoY)	-10.84%	-32.82%	-8.52%	76.93%	237.78%	628.60%
Cost of Revenue	202.51	196.79	246.95	216.67	117.11	31.45
Gross Profit	40.61	42.05	108.6	172.01	102.56	33.59
Selling, General & Admin	102.48	107.89	95.88	92.62	50.42	17.03
Research & Development	0.39	0.41	0.39	0.63	1.24	1.58
Other Operating Expenses	27.67	19.35	9.64	29.63	14.4	6.18
Operating Expenses	133.02	129.94	108.5	131.78	72.51	34.79
Operating Income	-92.4	-87.89	0.11	40.23	30.05	-1.21
Interest Expense	-20.94	-20.65	-24.22	-14.69	-0.42	-0.26
Interest & Investment Income	4.03	2.7	5.38	0.84	0.13	0.02
Currency Exchange Gain (Loss)	-0.02	-0.02	-0.05	7.33	-4.54	0.6
Other Non Operating Income (Expenses)	-2.15	-2.15	-0.83	-0.27	-4.63	-0.26
EBT Excluding Unusual Items	-111.49	-108	-19.61	33.44	20.6	-1.11
Impairment of Goodwill	-	-	-63.1	-	-	-
Gain (Loss) on Sale of Investments	-12.5	-12.22	-3	-0.17	-1.87	-37.2
Asset Writedown	-	-	-4.59	-	-	-
Other Unusual Items	32.9	32.9	29.01	10.57	-	-
Pretax Income	-91.09	-87.32	-61.29	43.84	18.73	-38.31
Income Tax Expense	-16.5	-14.53	2.25	0.09	11.44	-2.27
Earnings From Continuing Operations	-74.6	-72.79	-63.53	43.75	7.29	-36.04
Minority Interest in Earnings	3.67	5	1.57	1.07	-2.6	-1.19
Net Income	-70.93	-67.8	-61.96	44.82	4.69	-37.23
Net Income to Common	-70.93	-67.8	-61.96	44.82	4.69	-37.23
Net Income Growth	-	-	-	855.63%	-	-
Shares Outstanding (Basic)	50	46	46	45	38	25
Shares Outstanding (Diluted)	50	46	46	45	41	25
Shares Change (YoY)	8.85%	0.65%	0.48%	11.05%	60.81%	9.00%
EPS (Basic)	-1.41	-1.48	-1.36	0.99	0.12	-1.47
EPS (Diluted)	-1.41	-1.48	-1.36	0.99	0.11	-1.47
EPS Growth	-	-	-	798.39%	-	-
Free Cash Flow	-18.5	-71.3	-56.25	31.53	16.11	-12.95
Free Cash Flow Per Share	-0.37	-1.55	-1.23	0.69	0.39	-0.51
Gross Margin	16.71%	17.61%	30.54%	44.26%	46.69%	51.65%
Operating Margin	-38.01%	-36.80%	0.03%	10.35%	13.68%	-1.85%
Profit Margin	-29.18%	-28.38%	-17.43%	11.53%	2.14%	-57.25%
Free Cash Flow Margin	-7.61%	-29.85%	-15.82%	8.11%	7.33%	-19.91%
EBITDA	-80.62	-78.22	8.29	51.93	37.45	2.05
EBITDA Margin	-33.16%	-32.75%	2.33%	13.36%	17.05%	3.15%
D&A For EBITDA	11.78	9.67	8.18	11.7	7.39	3.25
EBIT	-92.4	-87.89	0.11	40.23	30.05	-1.21
EBIT Margin	-38.01%	-36.80%	0.03%	10.35%	13.68%	-1.85%
Effective Tax Rate	-	-	-	0.21%	61.07%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q